nih.gov - website profile
Alzheimer’s Disease Medications Fact Sheet
Aducanumab is the only disease- modifying medication currently approved to treat Alzheimer’s. This medication is a human antibody, or immunotherapy, that targets the protein beta-amyloid and helps to reduce amyloid plaques, which are brain lesions associated with Alzheimer’s.
nih.gov Alternatives